Logo image of MURA

MURAL ONCOLOGY PLC (MURA) Stock Overview

NASDAQ:MURA - IE000LK2BOB4 - Common Stock

2.06 USD
0 (0%)
Last: 8/27/2025, 8:06:07 PM
2.06 USD
0 (0%)
After Hours: 8/27/2025, 8:06:07 PM

MURA Key Statistics, Chart & Performance

Key Statistics
52 Week High4.74
52 Week Low0.95
Market Cap35.68M
Shares17.32M
Float14.48M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-7.71
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO11-03 2023-11-03
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


MURA short term performance overview.The bars show the price performance of MURA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20 -30 -40

MURA long term performance overview.The bars show the price performance of MURA in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of MURA is 2.06 USD. In the past month the price decreased by -11.21%. In the past year, price decreased by -37.95%.

MURAL ONCOLOGY PLC / MURA Daily stock chart

MURA Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.65 367.55B
AMGN AMGEN INC 13.2 155.03B
GILD GILEAD SCIENCES INC 14.72 141.35B
VRTX VERTEX PHARMACEUTICALS INC 22.97 99.76B
REGN REGENERON PHARMACEUTICALS 12.86 62.21B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.53B
ARGX ARGENX SE - ADR 76.37 43.33B
ONC BEONE MEDICINES LTD-ADR 6.06 35.68B
INSM INSMED INC N/A 28.44B
BNTX BIONTECH SE-ADR N/A 24.76B
NTRA NATERA INC N/A 22.38B
BIIB BIOGEN INC 8.52 19.99B

About MURA

Company Profile

MURA logo image Mural Oncology Plc is a clinical-stage oncology company, which engages in the business of discovering and developing immunotherapies for patients with cancer. The firm is leveraging its protein engineering platform to develop cytokine-based immunotherapies for the treatment of cancer. The company leverages its in-cytokine biology, immune cell modulation and protein engineering capabilities to develop immunotherapies. The firm is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers, particularly those with limited treatment options available. Its portfolio of programs includes Nemvaleukin alfa (Nemvaleukin)-IL-2, IL-12, and IL-18. Nemvaleukin is an engineered interleukin-2 (IL-2) variant designed to harness the potent anti-cancer capabilities of high-dose rhIL-2 while minimizing toxicity by selectively activating cancer-fighting CD8 T cells and NK cells. The tumor-targeted split IL-12 program focuses on delivering the therapeutic potential of IL-12 by splitting it into inactive component.

Company Info

MURAL ONCOLOGY PLC

10 Earlsfort Terrace

DUBLIN IE

Employees: 104

MURA Company Website

MURA Investor Relations

Phone: 35319058020

MURAL ONCOLOGY PLC / MURA FAQ

What is the stock price of MURAL ONCOLOGY PLC today?

The current stock price of MURA is 2.06 USD.


What is the ticker symbol for MURAL ONCOLOGY PLC stock?

The exchange symbol of MURAL ONCOLOGY PLC is MURA and it is listed on the Nasdaq exchange.


On which exchange is MURA stock listed?

MURA stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for MURAL ONCOLOGY PLC stock?

9 analysts have analysed MURA and the average price target is 6.12 USD. This implies a price increase of 197.09% is expected in the next year compared to the current price of 2.06. Check the MURAL ONCOLOGY PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is MURAL ONCOLOGY PLC worth?

MURAL ONCOLOGY PLC (MURA) has a market capitalization of 35.68M USD. This makes MURA a Nano Cap stock.


How many employees does MURAL ONCOLOGY PLC have?

MURAL ONCOLOGY PLC (MURA) currently has 104 employees.


What are the support and resistance levels for MURAL ONCOLOGY PLC (MURA) stock?

MURAL ONCOLOGY PLC (MURA) has a support level at 2.05 and a resistance level at 2.07. Check the full technical report for a detailed analysis of MURA support and resistance levels.


Should I buy MURAL ONCOLOGY PLC (MURA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MURAL ONCOLOGY PLC (MURA) stock pay dividends?

MURA does not pay a dividend.


What is the Price/Earnings (PE) ratio of MURAL ONCOLOGY PLC (MURA)?

MURAL ONCOLOGY PLC (MURA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.71).


What is the Short Interest ratio of MURAL ONCOLOGY PLC (MURA) stock?

The outstanding short interest for MURAL ONCOLOGY PLC (MURA) is 1.75% of its float. Check the ownership tab for more information on the MURA short interest.


MURA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

MURA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to MURA. MURA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MURA Financial Highlights

Over the last trailing twelve months MURA reported a non-GAAP Earnings per Share(EPS) of -7.71. The EPS increased by 17.06% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -168.07%
ROE -250.33%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%5.38%
Sales Q2Q%N/A
EPS 1Y (TTM)17.06%
Revenue 1Y (TTM)N/A

MURA Forecast & Estimates

9 analysts have analysed MURA and the average price target is 6.12 USD. This implies a price increase of 197.09% is expected in the next year compared to the current price of 2.06.


Analysts
Analysts77.78
Price Target6.12 (197.09%)
EPS Next Y19.32%
Revenue Next YearN/A

MURA Ownership

Ownership
Inst Owners57.85%
Ins Owners1.82%
Short Float %1.75%
Short Ratio1.48